بوابة الشروق
بوابة الشروق
Ready to play
Ready to play
The article revolves around the statements made by Dr. Hossam Abdel Ghaffar, the official spokesperson for the Ministry of Health and Population, regarding the effectiveness and safety of both local and imported insulin in Egypt. He confirmed that the price of the medication does not reflect its efficacy but is influenced by other factors such as transportation and production costs. He explained that the local product generally has a lower price due to reduced input costs. He also clarified that the Egyptian Drug Authority continuously monitors the quality of medicines, with stricter oversight on local products from the beginning of manufacturing. Furthermore, approval by the World Health Organization ensures the medicine's eligibility for international circulation. He emphasized that the quality of local medicines depends on the efficiency of the regulatory bodies authorized to oversee them and that the product adheres to international standards.
Notice: This Is an AI-Generated Summary
Comments (0)